Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019

From Critical Care Explorations.

The authors state that inconclusive clinical evidence should not be a reason for abandoning CST in COVID-19-associated ARDS.

Until results of more clinical trials are available, there is no justification based on available evidence and professional ethics to categorically deny the use of CST in severe life-threatening "cytokine storm" associated with COVID-19 in hospitals not involved in a RCT.

Authors:
Jesús Villar, MD, PhD
Marco Confalonieri, MD
Stephen M. Pastores, MD, MACP, FCCP, FCCM
G. Umberto Meduri, MD

Estimated Time: 14:40 min